Skip to main content
Premium Trial:

Request an Annual Quote

U. of Cambridge, Cancer Research UK, Perlegen Team Up for Breast Cancer Genotyping Study

NEW YORK, Feb. 16 (GenomeWeb News) - Researchers at the University of Cambridge, UK, Cancer Research UK and its technology transfer arm, and Perlegen Sciences will collaborate in a genotyping study to find genetic variations associated with breast cancer, the institutions said today.


Cancer Research UKprovides the funding for the project.


Perlegen Sciences will determine over 200 million genotypes in DNA samples collected from breast cancer patients in the UKand healthy women enrolled in the European Prospective Investigation of Cancer study. Initial results will be validated by Cambridgeresearchers, who plan to analyze several thousand additional samples.

The Scan

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.

Coronary Artery Disease Risk Loci, Candidate Genes Identified in GWAS Meta-Analysis

A GWAS in Nature Genetics of nearly 1.4 million coronary artery disease cases and controls focused in on more than 200 candidate causal genes, including the cell motility-related myosin gene MYO9B.

Multiple Sclerosis Contributors Found in Proteome-Wide Association Study

With a combination of genome-wide association and brain proteome data, researchers in the Annals of Clinical and Translational Neurology tracked down dozens of potential multiple sclerosis risk proteins.

Quality Improvement Study Compares Molecular Tumor Boards, Central Consensus Recommendations

With 50 simulated cancer cases, researchers in JAMA Network Open compared molecular tumor board recommendations with central consensus plans at a dozen centers in Japan.